36 results about "Transplanted kidney" patented technology

The use of (R).-ibuprofen methanesulfonamide is described for the preparation of medicaments for the treatment and prevention of functional injury resulting from rejection reactions of transplanted organs. In particular, the use of non-toxic salts of (R)-ibuprofen methanesulfonamide, such as the (L)-lysine salt, is described for the prevention and the treatment of rejection reactions of transplanted kidneys.

The invention relates to the technical field of medical devices, in particular to a continuous refrigeration system for kidney transplantation operations, including: a kidney bag, a kidney bag opening, a kidney door opening, an extracorporeal ring, an inner ring, pull wires, an inner pull ring, and an outer pull ring; The upper end of the bag is opened with a kidney bag opening for the transplanted kidney and smoothie mixture to enter the interior of the kidney bag. The lower end of the kidney bag is opened with a kidney door opening. The opening of the kidney bag is supported and expanded, the upper ring of the kidney bag is provided with an internal ring, and the internal ring is placed in the body of the patient whose kidney has been transplanted. Pull ring, the outer pull ring is connected to the end of the pull wire. In the present invention, the kidney bag is pulled into the kidney anastomosis position in the body through the inner pull ring, and the kidney bag is pulled out through the outer pull ring after surgery, which solves the problem of the low temperature protection bag for the kidney being placed. It is inconvenient to enter the human body and take it out after surgery.

The invention relates to an early diagnosis kit and an early warning kit, in particular to an early diagnosis and early warning kit for transplanted kidney rejection reaction and a use method of the kit, and further to some proteins applied in the early warning of transplanted kidney acute rejection reaction or transplanted kidney rejection reaction. By applying a liquid protein chip (luminex) detection technique, the expression level of 96 cytokines / chemokines and receptors thereof in 266 serum samples from 142 patients having acute transplanted kidney rejection reaction and transplant recipients with stable function of transplanted kidneys are monitored and comprehensively analyzed. An early warning system for the transplanted kidney rejection reaction comprising at least one combined marker and an early diagnosis system for the transplanted kidney rejection reaction comprising at least one factor combined marker are established. The prediction and accuracy rate of the acute rejection achieve 98.6%, and the internal cross validation rates are 97.1% and 97.2%, respectively.

The present invention provides an organ preservation solution and its preparation method and application. The preservation solution contains soluble TNF receptor and soluble IL-1 receptor or a carrier expressing the receptor. The application of the preservation solution can effectively reduce the host-versus-graft and graft-versus-host reactions in the process of organ transplantation, prolong the survival time of the graft, and improve the survival rate of the graft in the host body, so it can be effectively applied to organ transplantation, including Transplantation of vital organs such as kidneys, livers, and hearts.

A system (100) for noninvasively detecting an immune state of a transplanted kidney is applicable to the technical field of ultrasonic diagnosis automation after a kidney transplantation operation. The system (100) for noninvasively detecting an immune state of a transplanted kidney comprises: a data management module (10), used for obtaining, by means of networking, personal data and ultrasonic detection data of a patient for one or more times of detection according to identity recognition information of the patient; an ultrasonic connection module (20), used for accessing an ultrasonic detector and importing current ultrasonic detection data of the transplanted kidney; an analysis and processing module (30), used for selecting a computing model according to the personal data of the patient, and obtaining an analysis result of the ultrasonic detection data; and a result output module (40), used for formatting the analysis result and outputting the result according to the transplanting time of the patient and the analysis processing result. Accordingly, the system (100) collects and obtains clinical data and ultrasonic detection data of a patient, performs automatic / semi-automatic module combination, performs automatic classification operation, and finally, outputs an image-text integrated result, reduces the working load of a doctor, and facilitates result understanding.

The invention discloses a kidney transplantation device, which comprises a supporting platform, a lifting mechanism, a clamping mechanism and a cutting mechanism. The function of the supporting platform is to carry the whole device. The lifting mechanism moves the scalpel to the required Height, the clamping mechanism realizes the cutting movement of the scalpel through the gear and the lead screw, and then turns the scalpel upwards through the gear movement to clamp the kidney. The function of the cutting mechanism is to clamp the blood vessel and cut the blood vessel. The structure of the device Simple, safe, reliable, and highly automated.

The invention discloses a metabolic composition for preoperative early warning and delayed recovery of transplanted kidneys of donated donors after cardiac death, which consists of ascorbic acid, diaminopimelic acid, cinnamic acid, ureidoisobutyric acid, androstenedione, One or more of the seven metabolites of 3‑oxoctanoic acid and uroporphyrin. The invention also discloses a screening method for the metabolic composition used for early warning of the delayed recovery of the transplanted kidney of the donated donor after cardiac death. The binding indicator rate was 0.823, and the binding indicator rate of cinnamic acid, ureidoisobutyric acid, androstenedione, 3‑oxoctanoic acid and uroporphyrin was 0.98.